Indicators of Quality of Clinical Care for Type 2 Diabetes Patients in Primary Health Care Centers in Qatar: A Retrospective Analysis

Table 3

Distribution of patients (N = 643) by clinical outcome indicators against BRFSS, CDC/NCCDPHP (2008) benchmark.

No.	Variable	Values	Frequency	PHCC results (%)	BRFSS baseline 2008 (%)	BRFSS target by 2020 (%)	z-score	value
1.	HbA1c (%)	<7.0%	223	35.5	53.1	NA	−8.49	<0.0001
		7.0–7.9%	174	27.7	—	—
		8.0–8.9%	100	15.9	—	—
		9.0–9.9%	67	10.7	—	—
		≥10.0%	64	10.2	—	—
2.	BP control (<140/90)	Controlled	440	70.2	51.8	57.0	9.10	<0.0001
		Uncontrolled	187	29.8	—	—
3.	LDL level (mmol/L)	<2.6	397	73.8	53.0	58.3	9.52	<0.0001
		2.6–4.0	117	21.7	—	—
		≥4.1	24	4.5	—	—
4	Annual U-ACR measurement ([albuminuria (UCR <3.0) (mg/mmol)]			80.9	33.6	37.0	36.80	<0.0001
		Present	204	39.2	—	—
		Absent	316	60.8	—	—
5.	Annual eye examination (retinopathy)	Present	56	72.3 8.7	53.4	58.7	9.06	<0.0001
		Absent	587	91.3	—	—
6	Comprehensive foot examination			89.6	68.0	74.8	8.11	<0.0001
7.	Vitamin D level (ng/ml)	Normal (≥30)	90	17.5	—	—
		Insufficient (20–29)	223	43.4	—	—
		Deficient (<20)	201	39.1	—	—
8.	Pooled target (HBA1c, LDL-C, BP)		—	12.4	14.0	NA	−3.01	0.0026

U-ACR: urine albumin creatinine ratio; LDL-C: low-density lipoprotein cholesterol; HbA1c: glycated hemoglobin; BP: blood pressure; BRFSS: Behavioral Risk Factor Surveillance System, CDC/NCCDPHP, 2008; PHCC: Primary Health Care Corporation. Among nonsmokers. Source: American Diabetes Association (ADA) 2017 value [15] rather than (BRFSS), CDC/NCCDPHP [11].